Molecular Epidemiology/ Biomarkers/ Pharmacogenetics

Type here to filter the list

(253) An Emulated Target Trial Case Study of Real-World Overall Survival in Second-line Maintenance Niraparib vs Active Surveillance in Patients with Recurrent Ovarian Cancer

Favorite
(254) Prevalence and prognosis of hypoxia-inducible factor-2α (HIF-2α) pathway gene mutations across tumor types

Favorite
(255) Biomarkers Predictive of a Response to Extended Endocrine Therapy in Breast Cancer: A Systematic Review

Favorite
(256) Dealing with time-varying treatments in observational studies: a qualitative methodological review and proposal of research framework

Favorite
(258) Evaluating the impact of 5-HTTLPR on metformin response in type II diabetes patients in a longitudinal cohort study

Favorite
(259) Non-squamous, Metastatic Non-small Cell Lung Cancer: Retrospective c-Met Overexpression Testing, Patient Characteristics, and Treatment Patterns

Favorite
(260) Characterizing the Distribution of Multiple Negative Control Outcome Risk Differences

Favorite
(261) CARMA-BROS: An efficient Basket/Umbrella Real-world Observational Study (BUROS) Design for Rare Cancer Subtypes

Favorite
(262) The diagnostic landscape of HRD testing based on cross-sectional survey of physicians and molecular biologists conducting testing (INDICATOR ONE)

Favorite
(263) EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois: CONTACT: Recruiting and Engaging Participants

Favorite
(265) Effect of CYP and NAT2 Gene Polymorphisms on Human Response to Artemisinin-Based Combination Therapies in Yaounde, Cameroon

Favorite
(266) BMP8B: A beacon of hope for a non-invasive diagnostic biomarker of NAFLD progression

Favorite
(267) Unbalanced microbial genomic sequences from East Africa limits global surveillance for antimicrobial resistance in non-typhoidal Salmonella

Favorite
(268) Issues of statine utilisation

Favorite
(269) Integration of Basket/Umbrella Real-world Observational Studies (BUROS) into International Epidemiological Consortia to Inform Cancer Clinical Course and Disease Epidemiology

Favorite
(270) Building Fit-For-Purpose Real-World Clinicogenomic Data in Aesthetics for Personalized Skin Care Goals

Favorite